- Home
- PBYI vs CXDO Comparison
PBYI vs CXDO Comparison
Compare PBYI & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- CXDO
- Stock Information
- Founded
- PBYI 2010
- CXDO 1995
- Country
- PBYI United States
- CXDO United States
- Employees
- PBYI N/A
- CXDO N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- CXDO Telecommunications Equipment
- Sector
- PBYI Health Care
- CXDO Telecommunications
- Exchange
- PBYI Nasdaq
- CXDO Nasdaq
- Market Cap
- PBYI 152.4M
- CXDO 169.5M
- IPO Year
- PBYI N/A
- CXDO 1998
- Fundamental
- Price
- PBYI $3.28
- CXDO $5.38
- Analyst Decision
- PBYI Strong Buy
- CXDO Strong Buy
- Analyst Count
- PBYI 1
- CXDO 2
- Target Price
- PBYI $7.00
- CXDO $8.75
- AVG Volume (30 Days)
- PBYI 375.3K
- CXDO 238.7K
- Earning Date
- PBYI 05-08-2025
- CXDO 05-06-2025
- Dividend Yield
- PBYI N/A
- CXDO N/A
- EPS Growth
- PBYI 143.51
- CXDO 51.44
- EPS
- PBYI 0.77
- CXDO 0.09
- Revenue
- PBYI $232,709,000.00
- CXDO $62,609,000.00
- Revenue This Year
- PBYI N/A
- CXDO $12.77
- Revenue Next Year
- PBYI N/A
- CXDO $11.09
- P/E Ratio
- PBYI $4.25
- CXDO $60.59
- Revenue Growth
- PBYI 2.68
- CXDO 13.85
- 52 Week Low
- PBYI $2.23
- CXDO $2.92
- 52 Week High
- PBYI $4.13
- CXDO $7.34
- Technical
- Relative Strength Index (RSI)
- PBYI 52.36
- CXDO 49.12
- Support Level
- PBYI $3.14
- CXDO $5.08
- Resistance Level
- PBYI $3.45
- CXDO $5.79
- Average True Range (ATR)
- PBYI 0.19
- CXDO 0.30
- MACD
- PBYI 0.01
- CXDO -0.05
- Stochastic Oscillator
- PBYI 51.19
- CXDO 31.02
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.